Reddit Posts
opinions on this stock? and also palentir
MariMed Posts $4.2M Loss in Q3 Despite Maryland Rec Launch
What the heck is going on with MRMD after earnings?
Echelon Wealth Partners Reaffirms Their Buy Rating on MariMed (MRMD)
$MRMD Safe banking anticipation propelling pot stocks for the next couple weeks.
One of the most profitable US Cannabis companies will be reporting tomorrow after the bell
Q4 vs Q1 - $MRMD $TRSSF $GDNSF $CCHWF $PLNHF $SHWZ
RLBD (otcqb) I’m expecting huge moves in the coming weeks 1000%+
PennyStockRumble!!! MRMD, TRSSF, JUSHF, ACRDF, CCHWF, GDNSF ... 2020 vs 2021
MariMed Doubles Full Year Revenue and Adjusted EBITDA As It Reports Fourth Quarter and Full Year 2021 Earnings :: MariMed Inc. (MRMD)
MRMD: Small, profitable POT stock continues to expand
Echelon Capital initiates coverage of high quality pot stock
Echelon Capital initiates coverage on top quality pot company
Echelon Capital's Andrew Semple initiates coverage on MRMD
$10k on MRMD LFG! Check the financials and tell me I’m wrong!
Mentions
VERY, and MRMD has already been USA domiciled
MRMD my goat, carrying my port to reaching +100% yrs
Best details: The commission's framework rolls out three new license types: Supplemental, for existing cannabis businesses to add on site consumption into their operations. Hospitality, for non-cannabis businesses to host consumption activities with qualifying marijuana establishments. Event organizer, for cannabis businesses to host consumption events. Good for MariMed MRMD who has 3 dispensaries, the max for the state. It’s a free opportunity to a new revenue stream.
It is, been waiting since the last run up in 2021 for this type of catalyst. High Tide I like as well, made money but sold the position, I miss it. Their retail presence and strong balance sheet make them shine. MariMed MRMD is my choice for this major rally (assuming it happens), becuase they will be a growth stock withen the sector. Higher risk, but I want a company I can really have a lot of equity in since we are at such early stages. MariMed pays their 280e Tax, unlike 90% of other operators. Prudent capital expansion and targeting a few states without going too large. Innovative drink powder product. Humble management. Obviously, I like the stock.
$MRMD is going to make me so much money!
[MRMD ](http://bettyseddies.com)
[MRMD ](http://Marimedinc.com)
[bettyseddies.com (MRMD)](http://bettyseddies.com)
can't find MRMD in IBKR app
U.S. Supreme Court To Discuss Case Challenging Federal Marijuana Prohibition This Week. $MRMD
#Cannabis stocks -> $MRMD
MRMD has edibles. Most companies will process it into concentrates such as RSO oil to be take sublingual. $MRMD
**📊 280E Tax Relief – Cannabis MSO Estimates (Rescheduling → Schedule III)** Rescheduling could remove 280E, letting companies deduct normal expenses. Analyst research (Zuanic, Water Tower, Whitney) shows potential annual savings: |Company|2025 Revenue|Est. 280E Savings| |:-|:-|:-| |Curaleaf (CURLF)|$1.3–1.5B|$150–200M| |Trulieve (TCNNF)|$1.1–1.3B|$120–180M| |Green Thumb (GTBIF)|$1.0–1.2B|$100–150M| |Verano (VRNOF)|$900–1,000M|$80–120M| |Cresco (CRLBF)|$800–900M|$70–100M| |Jushi (JUSHF)|$250–500M|Up to \~$514M| |Cannabist / Columbia Care|$300–360M|$35–50M| |Planet 13 (PLNHF)|$95–110M|$9–15M| |MariMed (MRMD)|$150–180M|$15–25M| **Takeaways:** * Total U.S. MSO tax savings could reach **$2–3B+ annually**. * Largest absolute beneficiaries: Curaleaf, Trulieve, Green Thumb. * High % upside: Jushi, Planet 13, MariMed. * Retroactive refunds are speculative; cash depends on DEA/HHS action & IRS guidance.
Yea its at the mercy of its peers and MSOS. There will be more beta in MRMD when the major catalysts hit than the etf of course, so just hanging in there for now. Long term MRMD is prudent financially, innovative in their products, and focused on quality. I think after 5 years they emerge out of the group of operators as a winner.
Lawmakers could force the DEA to remove cannabis from the Schedule-1 list, with a 90-day time limit, to allow the FDA to study it for medical value so insurance companies can help patients obtain it at hospitals and pharmacies such as Walgreens, Costco, or CVS provided by existing multi-state operators such as MRMD (Marimed Inc.)
Lawmakers could force the DEA to remove cannabis from the Schedule-1 list, with a 90-day time limit, to allow the FDA to study it for medical value so insurance companies can help patients obtain it at hospitals and pharmacies such as Walgreens, Costco, or CVS provided by existing multi-state operators such as MRMD (Marimed Inc.), CURLF (Curaleaf), TCNNF (Trulieve) and many other multi-state operators.
I study the sympathy between MRMD and MSOS to see how they move. Usually MariMed lags the moves up or down and sometimes it has more correlation than others. The MSOS etf doesnt hold much MariMed, so their share buying/selling into the underlying stock is a bit insulated which I like. The etf buying and dumping shares drives the price so I like being a bit removed from that poorly managed fund and the moves it makes.
The licenses are worth money. The edibles. The weed. Lawmakers could force the DEA to remove cannabis from the Schedule-1 list, with a 90-day time limit, to allow the FDA to study it for medical value so insurance companies can help patients obtain it at hospitals and pharmacies such as Walgreens, Costco, or CVS provided by existing multi-state operators such as MRMD (Marimed Inc.)
I have 92,000 of MRMD. Looking to sell above 1.00
I want to draw a creep 3rd guy labeled MRMD
MRMD is going to run 🏃♂️
#MRMD <----- rune essence 10gp/ea
Younger Dryas was an ice dam in the St. Lawrence river. MRMD
They still did better than MRMD.
Ive been telling people to sell VFF and buy MRMD for over a year. I used to work for GTBIF as an assistant manager.
I just checked. They have good net debt. But idk. The chart sucks. Im already getting fucked on MRMD 
It coul break either way. I like limit orders with grid. MRMD might full send soon.
It will go up later and people might chase it. I loaded 50,000 MRMD long.
Wow, Powell and Yellen are finally getting married? #MRMD
Lawmakers could force the DEA to remove cannabis from the Schedule-1 list, with a 90-day time limit, to allow the FDA to study it for medical value so insurance companies can help patients obtain it at hospitals and pharmacies such as Walgreens, Costco, or CVS provided by existing multi-state operators such as MRMD (Marimed Inc.), CURLF (Curaleaf), TCNNF (Trulieve) and many other multi-state operators.
Being honest I’ve never even heard of MRMD
What is it? Ill buy 100 of NFE of you buy 100 of MRMD.
You could buy 139 shares of MRMD and of cannabis moons then you get $139-$1,390.
Fuck it, I bought 50,000 of MRMD long.
Im trying not to buy big cannabis but keep loading MRMD. It's a win/win. If big cannabis fails then it allows opportunities for small businesses.
Congress can pass a simple statutory directive ordering the DEA to remove cannabis from Schedule I within a fixed window, and because scheduling authority ultimately comes from the Controlled Substances Act, lawmakers can override the agency with a single amendment that bypasses the slow administrative process. Once removed from Schedule I, the FDA immediately gains freedom to run full clinical evaluations, allowing cannabis to enter the same medical review pipeline used for any other therapeutic, which reshapes how investors view long-term regulatory clarity. A congressional mandate would also trigger automatic coordination between the DEA, FDA, and HHS, because descheduling forces these agencies into a compliance posture rather than a discretionary one, eliminating the political bottleneck that normally stalls progress. That fast alignment is exactly what markets tend to reward, since it takes the uncertainty premium off U.S. cannabis operators and opens the door for mainstream institutions that have been waiting for a clear federal rule. Once the FDA enters the picture with formal pathways, insurers can legally reimburse cannabis-based treatments through standard medical benefit structures, and hospitals or major retail pharmacies can dispense products sourced from established operators. That shift converts cannabis from a fragmented state-only model into a federal healthcare product, positioning companies like MRMD, CURLF, and TCNNF to plug directly into the national distribution chains they’ve been structurally built for. Congress can also attach descheduling to a broader health or appropriations bill, a tactic used constantly to move policy changes without relying on standalone votes. That approach makes passage much easier, because it folds cannabis into routine legislative cycles, sidestepping headline political fights and letting the reform ride through on a must-pass vehicle—something markets interpret as near-guaranteed execution once language is included. All of this creates a straightforward pathway: congressional directive → DEA compliance → FDA evaluation → insurance coverage → mainstream pharmacy distribution → national scale for operators. For lawmakers, it’s one of the cleanest federal reforms available; for the sector, it’s a regulatory unlock that allows U.S. cannabis stocks to function like normal consumer-health companies instead of siloed state-restricted plays.
Yea. 5 years away. Slow decline. Overhyped. Weed is undervalued. I bought MRMD.
They shouldn't be asking. Jk. Tbh, i bought MRMD for weed stock diversification. Can't miss the b-coin.
MRMD. They can't encrypt weed.
 MRMD
Lawmakers could force the DEA to remove cannabis from the Schedule-1 list, with a 90-day time limit, to allow the FDA to study it for medical value so insurance companies can help patients obtain it at hospitals and pharmacies such as Walgreens, Costco, or CVS provided by existing multi-state operators such as MRMD (Marimed Inc.), CURLF (Curaleaf), TCNNF (Trulieve) and many other multi-state operators.
Congress could require the DEA to move cannabis out of Schedule I within 90 days, instantly opening the door for a full scientific review. Once it’s descheduled, the FDA would run a complete evaluation—clinical data, therapeutic applications, dosing ranges, safety profiles, manufacturing standards, purity requirements, and how cannabis fits into existing classes of regulated medicines. HHS would take those findings and issue a formal medical determination, creating a nationally recognized foundation for regulated therapeutic use. That shift unlocks insurance coverage because FDA and HHS recognition allows CMS and private insurers to treat cannabis like any other approved treatment. Hospitals, integrated health networks, and major pharmacy chains could then stock and dispense standardized, FDA-compliant formulations. Operators like MRMD, CURLF, and TCNNF—already functioning in tightly regulated state systems—could transition into federally compliant production, scaling supply across state lines and eventually into international medical markets under unified standards. The sequence becomes: Congress directs DEA → DEA deschedules → FDA defines medical standards → HHS certifies medical use → insurers reimburse → pharmacies and hospitals dispense → regulated producers supply a national and global market.
Ill buy IVP if you buy MRMD 🫡
Honestly your info sounds more like employee rumor than actual fact. >”Eugene Monroe the NFL football player overhyped GTI so is way more talk than actual profit” Fact: GTI is the most profitable cannabis company consistently over the last several years. No idea what you’re talking about. I don’t even know who Eugene Monroe is. >”They are using funds from Jim Beam to prop up their financials” Bullshit. Where’s the proof. This is a publicly traded company with rigorously reported financials. Sounds like rumor. >”GTI corporate office does not consume cannabis” I’ve literally seen video of Ben Kovler taking bong rips. He very clearly consumes a lot of cannabis and is often posting this on social media. I don’t necessarily think this is a good thing, but it goes to show your statement is false. Anyway I’m not saying MRMD is bad. I’ve seen others on the weedstocks sub marketer case like you are. GTI has always been the favorite of institutional investors and will likely recognize the benefits from that if cannabis is rescheduled or other restrictions are loosened.
You should buy more GTBIF. They would love your money. I hope MRMD goes lower so I get more.
I saw behind the scenes at GTI. MRMD is undervalued.
MRMD still have very low volume. Thin level 2.
Lawmakers could order the DEA to take cannabis off Schedule I within 90 days, clearing the way for FDA review and opening the door for insurance-covered access through hospitals and major pharmacies like Walgreens, Costco, and CVS, supplied by existing MSOs such as MRMD, CURLF, TCNNF, and others.
MRMD will be flat and lower again.
Lol, THCa is the compound in weed. MRMD is a weed company. So, you were half correct. Hah
MRMD and THCa diamond hands.
Burry wouldn't short MRMD... too much of a pussy.
Glad you did good. I bought MRMD and not doing well.
Yea but I bought 50,000 of MRMD so its not saying much coming from me.
At this point MRMD will reach $1.00 before he signs the bill.
Did they get this out of MRMD's playbook. That stock sucks.
DXY is opposite of bitco8n and SPY. News... MRMD is the worst company.
SPY trades opposite of the dollar. MRMD still sucks.
I already did on MRMD... twice.
Its 50/50 NVDA. It still won't impact MRMD.
I went all in on MRMD and it didnt work out well.
Don't buy MRMD. It always goes down.
MRMD is not a cannabis company.
Ill buy 100 shares if you buy MRMD.
It still won't impact MRMD. Always goes down.
I do this with all stocks. Limit order with a grid pattern. MRMD is at 0.08
Hoping this happens to MRMD one day... with me still holding.
Ill buy 100 of AZI if you buy 100 of MRMD. Its at 0.08